Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor

Biochemical and Biophysical Research Communications

Volumn 372, Issue 4, 2008, Pages 821-825

  Kanagawa, Naoko ^a   Gao, Jian Qing ^a,b   Motomura, Yoshiaki ^a   Yanagawa, Tatsuya ^a   Mukai, Yohei ^a   Yoshioka, Yasuo ^a   Okada, Naoki ^a   Nakagawa, Shinsaku ^a  

^a OSAKA UNIVERSITY   (Japan)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Adenoviral vector; Gene therapy; IL 12; Meth A fibrosarcoma; Tumor infiltrating immune cell

Indexed keywords

ADENOVIRUS VECTOR; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG RESPONSE; EMBRYO; FEMALE; FIBROSARCOMA; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS; INTERLEUKIN-12; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED BALB C; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC;

MURINAE; MUS MUSCULUS;

EID: 45449098667     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.129     Document Type: Article

References (23)

1. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chang S., Koudon R., Sherman F., Perussia B., and Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170 (1989) 827-845
2. Chan S.H., Perssia B., Gupta J.W., Kobayashi M., Pospisil M., Young H.A., Wolf S.G., Young D., Clark S.C., and Trinchieri G. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173 (1991) 869-879
3. Wolf S.F., Temple P.A., Kobayashi M., Young E., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., Hewick R.M., Kelleher K., Herrmann S.H., Clark S.C., Azzoni L., Chan S.H., Trinchieri G., and Perussia B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146 (1991) 3074-3081
4. Manetti R., Parronchi P., Giudizi M.G., Piccini M.P., Maggi E., Trinchieri G., and Romagnani S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177 (1993) 1199-1204
5. Car B.D., Eng V.M., Lipman J.M., and Anderson T.D. The toxicology of interleukin-12: a review. Toxicol. Pathol. 27 (1999) 58-63
6. Marshall E. Cancer trial of interleukin-12 halted. Science 268 (1995) 1555
7. Colombo M.P., Vagliani M., Spreafico F., Parenza M., Chiodoni C., Melani C., and Stoppacciaro A. Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res. 56 (1996) 2531-2534
8. Okada Y., Okada N., Mizuguchi H., Takahashi K., Hayakawa T., Mayumi T., and Mizuno N. Optimization of antitumor efficacy and safety of in vivo cytokine gene therapy using RGD fiber-mutant adenovirus vector for preexisting murine melanoma. Biochim. Biophys. Acta 1670 (2004) 172-180
9. Gao J.Q., Sugita T., Kanagawa N., Iida K., Eto Y., Motomura Y., Mizuguchi H., Tsutsumi Y., Hayakawa T., Mayumi T., and Nakagawa S. A single intratumoral injection of a fiber-mutant adenoviral vector encoding interleukin 12 induces remarkable anti-tumor and anti-metastatic activity in mice with Meth-A fibrosarcoma. Biochem. Biophys. Res. Commun. 328 (2005) 1043-1050
10. Gao J.Q., Kanagawa N., Motomura Y., Yanagawa T., Sugita T., Hatanaka Y., Tani Y., Mizuguchi H., Tsutsumi Y., Mayumi T., Okada N., and Nakagawa S. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer. Gene Ther. 14 (2007) 491-502
11. Ogawa M., Umehara K., Yu W.G., Uekusa Y., Nakajima C., Tsujimura T., Kubo T., Fujiwara H., and Hamaoka T. A critical role for a peritumoral stromal reaction in the induction of T-cell migration responsible for interleukin-12-induced tumor regression. Cancer Res. 59 (1999) 1531-1538
12. Iwasaki M., Yu W.G., Uekusa Y., Nakajima C., Yang Y.F., Gao P., Wijesuriya R., Fujiwara H., and Hamaoka T. Differential IL-12 responsiveness of T cells but not of NK cells from tumor-bearing mice in IL-12-responsive versus -unresponsive tumor models. Int. Immunol. 12 (2000) 701-709
13. Uekusa Y., Yu W.G., Mukai T., Gao P., Yamaguchi N., Murai M., Matsushima K., Obika S., Imanishi T., Higashibata Y., Nomura S., Kitamura Y., Fujiwara H., and Hamaoka T. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice. Cancer Res. 62 (2002) 3751-3758
14. Mizuguchi H., Koizumi N., Hosono T., Utoguchi N., Watanabe Y., Kay M.A., and Hayakawa T. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther. 8 (2001) 730-735
15. Mizuguchi H., and Kay M.A. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum. Gene Ther. 9 (1998) 2577-2583
16. Mizuguchi H., and Kay M.A. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. Hum. Gene Ther. 10 (1999) 2013-2017
17. Dialynas D.P., Quan Z.S., Wall K.A., Pierres A., Quintans J.J., Loken M.R., Pierres M., and Fitch F.W. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131 (1983) 2445-2451
18. Ledbetter J.A., and Herzenberg L.A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47 (1979) 63-90
19. Lugade A.A., Sorensen E.W., Gerber S.A., Moran J.P., Frelinger J.G., and Lord E.M. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184 (1996) 963-969
20. Tannenbaum C.S., Tubbs R., Armstrong D., Finke J.H., Bukowski R.M., and Hamilton T.A. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J. Immunol. 161 (1998) 927-932
21. Ogawa M., Tsutsui T., Zou J.P., Mu J., Wijesuriya R., Yu W.G., Herrmann S., Kubo T., Fujiwara H., and Hamaoka T. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12. Cancer Res. 57 (1997) 2216-2222
22. 1 integrin/VCAM-1, and LFA-1 adhesion pathways. J. Exp. Med. 197 (2003) 1255-1267
23. Lugade A.A., Moran J.P., Gerber S.A., Rose R.C., Frelinger J.G., and Lord E.M. Radiation-induced IFN-γ production within the tumor microenvironment influences antitumor immunity. J. Immunol. 180 (2008) 3132-3139